Osimertinib Versus Comparator EGFR TKI as First-Line Treatment for EGFR-Mutated Advanced NSCLC: FLAURA China, A Randomized Study
奥希替尼与对照 EGFR TKI 作为 EGFR 突变晚期非小细胞肺癌一线治疗的疗效比较:FLAURA 中国随机研究
期刊:Targeted Oncology
影响因子:4
doi:10.1007/s11523-021-00794-6
Cheng, Ying; He, Yong; Li, Wei; Zhang, He-Long; Zhou, Qing; Wang, Buhai; Liu, Chunling; Walding, Andrew; Saggese, Matilde; Huang, Xiangning; Fan, Minhao; Wang, Jia; Ramalingam, Suresh S